ReviewJournal of obesity & metabolic syndrome2025
Hijacked Brain in Modern Obesity: Cue, Habit, Addiction, Emotion, and Restraint as Targets for Personalized Digital Therapy and Electroceuticals.
Review in Journal of obesity & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review of the Use of Digital Therapeutics for Obesity Treatment: Toward a Psychological Phenotyping.Advances in nutrition (Bethesda, Md.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global obesity epidemic can no longer be explained by personal choice or caloric excess alone. Mounting evidence points to underlying neurobehavioral dysfunction, exacerbated by environments engineered to promote overconsumption. Modern obesity is driven by five interrelated neurobehavioral factors: cue-evoked eating, habitual-context eating, food addiction, emotional eating, and restrained eating. These maladaptive eating patterns arise from a decoupling of homeostatic and hedonic brain circuits in an obesogenic environment. This review synthesizes evidence from neuroimaging, behavioral experiments, and animal studies to illustrate how each factor contributes to obesity risk and relapse after weight loss. We further discuss emerging interventions -including digital therapeutics (DTx) and electroceuticals-that target these drivers with increasing precision. DTx platforms deliver scalable, phenotype-informed interventions through cognitive-behavioral modules, real-time monitoring, and artificial intelligence-driven coaching. Electroceutical strategies, including non-invasive brain stimulation and vagus nerve modulation, show promise in reshaping dysfunctional circuits. Finally, we propose a neurobehavioral subtyping model to guide personalized obesity treatment, integrating brain-based phenotyping with multimodal interventions. This framework may offer a path toward sustained and mechanism-driven obesity care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.